Exploring the role of glucagon-like peptide-1 receptor agonists in critical illness: mechanisms, benefits, and clinical implications

Vidit G. Jogani, Osman Mohamed Elfadil, Jithinraj Edakkanambeth Varayil, Manpreet S. Mundi

Open source

DOI
10.1097/mcc.0000000000001294
Published
2025-06-12
Container
Current Opinion in Critical Care
Publisher
Ovid Technologies (Wolters Kluwer Health)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1097/mcc.0000000000001294,
  title = {Exploring the role of glucagon-like peptide-1 receptor agonists in critical illness: mechanisms, benefits, and clinical implications},
  author = {Vidit G. Jogani and Osman Mohamed Elfadil and Jithinraj Edakkanambeth Varayil and Manpreet S. Mundi},
  year = {2025},
  journal = {Current Opinion in Critical Care},
  doi = {10.1097/mcc.0000000000001294},
  url = {https://doi.org/10.1097/mcc.0000000000001294}
}

RIS

TY  - JOUR
TI  - Exploring the role of glucagon-like peptide-1 receptor agonists in critical illness: mechanisms, benefits, and clinical implications
AU  - Vidit G. Jogani
AU  - Osman Mohamed Elfadil
AU  - Jithinraj Edakkanambeth Varayil
AU  - Manpreet S. Mundi
PY  - 2025
JO  - Current Opinion in Critical Care
DO  - 10.1097/mcc.0000000000001294
UR  - https://doi.org/10.1097/mcc.0000000000001294
ER  - 

APA

Jogani, V. G., Elfadil, O. M., Varayil, J. E., & Mundi, M. S. (2025). Exploring the role of glucagon-like peptide-1 receptor agonists in critical illness: mechanisms, benefits, and clinical implications. Current Opinion in Critical Care. https://doi.org/10.1097/mcc.0000000000001294

Source records